Insulin in Pregnancy: Educational Reference

Educational overview of insulin use in pregnancy for gestational and pre-existing diabetes. All estimates shown are for reference only and must be supervised by an OB or maternal-fetal medicine specialist.

OB/MFM SPECIALIST SUPERVISION REQUIRED

Insulin dosing during pregnancy must ALWAYS be managed by an obstetrician (OB/GYN), maternal-fetal medicine (MFM) specialist, or an endocrinologist experienced in obstetric diabetes. Insulin requirements change dramatically across all three trimesters and immediately postpartum. Errors can harm both the mother and the developing baby. This page is for educational reference only — never self-adjust insulin during pregnancy.

🤰 Pregnancy Insulin Reference Estimator

Shows educational reference estimates only. All insulin decisions in pregnancy must be made with your OB or MFM specialist.

Pre-pregnancy or Current Weight

Diabetes Type

Trimester

🚨 Reminder: These are educational reference values only. Insulin in pregnancy must be prescribed and supervised by your OB or MFM team — never self-adjusted.

Reference Estimate

—Est. TDD range
units/day

—Basal ~40–50%
units/day

—Fasting BG target
(ADA pregnancy)

—1-hr postmeal target
(ADA pregnancy)

Notes for this trimester:

Insulin Requirements Across Pregnancy

Insulin requirements change dramatically across the three trimesters of pregnancy. Understanding these changes helps patients engage meaningfully with their obstetric diabetes team — it does not replace that team.

Trimester-Specific Dose Changes

Trimester	Insulin Sensitivity	Typical Dose Factor	Key Driver
1st (wks 1–12)	Increased or unchanged	0.7 u/kg (T1D)	Nausea may reduce food intake; some need less insulin
2nd (wks 13–27)	Decreasing	0.8 u/kg (T1D)	Placental hormones begin rising
3rd (wks 28–40)	Significantly reduced	0.9–1.0 u/kg (T1D)	HPL, progesterone, cortisol peak — strong insulin resistance
Postpartum	Rapidly normalises	Reduce ~50% immediately	Placenta delivered — insulin-blocking hormones clear rapidly

Sources: ADA Standards 2024 Section 15; ACOG Practice Bulletin 201.

Blood Glucose Targets in Pregnancy (ADA 2024)

Fasting: < 95 mg/dL (5.3 mmol/L)
1-hour post-meal: < 140 mg/dL (7.8 mmol/L)
2-hour post-meal: < 120 mg/dL (6.7 mmol/L)

These are tighter than non-pregnant targets. More frequent monitoring (6–8 checks/day or continuous glucose monitoring) is typically required. CGM is increasingly used and recommended for pregnant women with Type 1 and Type 2 diabetes.

DKA risk is elevated in pregnancy. Pregnant women with Type 1 diabetes can develop DKA at lower blood glucose levels than non-pregnant adults (so-called "euglycemic DKA"). Any illness, vomiting, or unusual ketone readings during pregnancy must be evaluated urgently by the obstetric team — do not manage at home without guidance.

Sources & References

American Diabetes Association. Standards of Medical Care in Diabetes — 2024. Section 15: Management of Diabetes in Pregnancy. Link
ACOG Practice Bulletin No. 201. "Pregestational Diabetes Mellitus." Obstet Gynecol. 2018;132(6):e228–e248.
Blumer I et al. "Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2013;98(11):4227–4249.

Last reviewed: June 2025

Frequently Asked Questions

How does insulin requirement change during pregnancy?

In the 1st trimester, sensitivity often increases slightly — some women with pre-existing Type 1 need less insulin, especially if nausea reduces food intake. The 2nd and 3rd trimesters bring progressive insulin resistance from placental hormones (HPL, progesterone, cortisol), often requiring 2–3x pre-pregnancy doses by week 36. Immediately after delivery, insulin sensitivity rapidly returns as the placenta clears — dose must be reduced immediately to avoid severe hypoglycemia.

Is insulin safe during pregnancy?

Yes. Insulin does not cross the placenta in significant amounts and is the preferred treatment for diabetes in pregnancy. Rapid-acting analogs lispro (Humalog) and aspart (NovoLog) and long-acting detemir (Levemir) and glargine (Lantus/Basaglar) have established pregnancy safety records. Uncontrolled blood glucose during pregnancy carries far greater risks to the fetus than insulin therapy itself. Your obstetric team will recommend the specific insulin type appropriate for your pregnancy.

What are blood glucose targets during pregnancy?

ADA targets for diabetes in pregnancy: fasting BG < 95 mg/dL, 1-hour post-meal < 140 mg/dL, 2-hour post-meal < 120 mg/dL. These are significantly tighter than non-pregnancy targets. Achieving them requires intensive monitoring — often 6–8 checks/day or continuous glucose monitoring — and frequent dose adjustments. Your OB or MFM team will set personalised targets for your pregnancy based on your specific history.

What is gestational diabetes and does it always need insulin?

Gestational diabetes mellitus (GDM) is glucose intolerance first diagnosed during pregnancy. Many cases — perhaps 70–80% — can be managed with diet and lifestyle changes alone. When diet fails to achieve glucose targets after 1–2 weeks, insulin is the preferred first pharmacological treatment (oral agents like metformin and glyburide are used in some protocols but are not FDA-approved for GDM). The decision to start insulin, the starting dose, and the monitoring plan must come from your obstetric team.

What happens to insulin dose after delivery?

After delivery, placental hormones clear rapidly. Women with pre-existing Type 1 or Type 2 diabetes must reduce their insulin dose immediately — often by 50% or more — to avoid severe postpartum hypoglycemia. This transition is managed by the obstetric and endocrine team. Women with GDM typically no longer need insulin after delivery but have a 50% lifetime risk of developing Type 2 diabetes and should be screened with a post-partum glucose test at 6–12 weeks and annually thereafter.